tiprankstipranks
Verrica Pharmaceuticals entered into amendment to license agreement with Torii
PremiumThe FlyVerrica Pharmaceuticals entered into amendment to license agreement with Torii
26d ago
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
PremiumPress Releases
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
26d ago
Verrica Pharmaceuticals price target raised to $14 from $13 at H.C. Wainwright
PremiumThe Fly
Verrica Pharmaceuticals price target raised to $14 from $13 at H.C. Wainwright
28d ago
Verrica Pharmaceuticals to Present at Upcoming Investor Conferences
PremiumPress ReleasesVerrica Pharmaceuticals to Present at Upcoming Investor Conferences
1M ago
Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024
PremiumPress Releases
Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024
1M ago
Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
PremiumPress Releases
Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
2M ago
Verrica Pharmaceuticals reports Q4 EPS (53c), consensus (53c)
PremiumThe FlyVerrica Pharmaceuticals reports Q4 EPS (53c), consensus (53c)
3M ago
Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference
PremiumPress Releases
Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference
3M ago
VRCA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
VRCA Earnings this Week: How Will it Perform?
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100